Weekly Roundup: November 2, 2018


Max Rex and Jack Rawson

Episode Description

The team analyze the new Medicare drug pricing plan unveiled by the Trump administration and the prospects of Vertex’s cystic fibrosis drug Symkevi which gained EU approval recently.
Presenter: Aparna Krishnan
Contributors: Max Rex and Jack Rawson

Latest episodes

Share this podcast